Emergent Resumes Production of Johnson & Johnson's Covid Vaccine
Jul 29 2021, 9:04 PM July 29 2021, 7:19 PM July 29 2021, 9:04 PM (Bloomberg) -- The U.S. Food and Drug Administration cleared Johnson & Johnsonâs Covid-19 vaccine manufacturer Emergent BioSolutions Inc. to resume production of the shot after a series of mishaps that led it to halt manufacturing. (Bloomberg) -- The U.S. Food and Drug Administration cleared Johnson & Johnsonâs Covid-19 vaccine manufacturer Emergent BioSolutions Inc. to resume production of the shot after a series of mishaps that led it to halt manufacturing. The Gaithersburg, Maryland-based contract manufacturer said ...